# Special Drug Use Surveillance of Entresto Tablets (Hypertension)

> **NCT05976230** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 1125 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Entresto

## Key facts

- **NCT ID:** NCT05976230
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-04
- **Primary completion:** 2025-05-29
- **Final completion:** 2025-05-29
- **Target enrollment:** 1125 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05976230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05976230, "Special Drug Use Surveillance of Entresto Tablets (Hypertension)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05976230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*